Cargando…
A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection
Classic salt-wasting 21-hydroxylase deficiency (21-OHD) often requires fludrocortisone (FC) replacement. However, the optimal dose of FC varies between patients and the dose needs to be adjusted depending on the degree of symptoms. Further, the aldosterone resistance due to urinary tract infections...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779137/ https://www.ncbi.nlm.nih.gov/pubmed/33409011 http://dx.doi.org/10.7759/cureus.11763 |
_version_ | 1783631272135884800 |
---|---|
author | Shimakawa, Urara Shigehara, Keiichi Kawabe, Yasuhiro Ouchi, Kazutaka Mori, Jun |
author_facet | Shimakawa, Urara Shigehara, Keiichi Kawabe, Yasuhiro Ouchi, Kazutaka Mori, Jun |
author_sort | Shimakawa, Urara |
collection | PubMed |
description | Classic salt-wasting 21-hydroxylase deficiency (21-OHD) often requires fludrocortisone (FC) replacement. However, the optimal dose of FC varies between patients and the dose needs to be adjusted depending on the degree of symptoms. Further, the aldosterone resistance due to urinary tract infections causes salt-wasting symptoms. We recently encountered a patient with 21-OHD who required up to 0.36 mg/day of FC in order to control hyperkalemia despite adequate hydrocortisone (HC) administration. This condition was presumed to be due to aldosterone resistance complications associated with urinary tract infections. Thus, if the initial treatment of 21-OHD with HC and FC is resistant, then one should consider complications that may cause aldosterone resistance, such as urinary tract infections. |
format | Online Article Text |
id | pubmed-7779137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-77791372021-01-05 A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection Shimakawa, Urara Shigehara, Keiichi Kawabe, Yasuhiro Ouchi, Kazutaka Mori, Jun Cureus Endocrinology/Diabetes/Metabolism Classic salt-wasting 21-hydroxylase deficiency (21-OHD) often requires fludrocortisone (FC) replacement. However, the optimal dose of FC varies between patients and the dose needs to be adjusted depending on the degree of symptoms. Further, the aldosterone resistance due to urinary tract infections causes salt-wasting symptoms. We recently encountered a patient with 21-OHD who required up to 0.36 mg/day of FC in order to control hyperkalemia despite adequate hydrocortisone (HC) administration. This condition was presumed to be due to aldosterone resistance complications associated with urinary tract infections. Thus, if the initial treatment of 21-OHD with HC and FC is resistant, then one should consider complications that may cause aldosterone resistance, such as urinary tract infections. Cureus 2020-11-29 /pmc/articles/PMC7779137/ /pubmed/33409011 http://dx.doi.org/10.7759/cureus.11763 Text en Copyright © 2020, Shimakawa et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Shimakawa, Urara Shigehara, Keiichi Kawabe, Yasuhiro Ouchi, Kazutaka Mori, Jun A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection |
title | A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection |
title_full | A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection |
title_fullStr | A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection |
title_full_unstemmed | A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection |
title_short | A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection |
title_sort | case of salt-wasting 21-hydroxylase deficiency with resistance to aldosterone due to urinary tract infection |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779137/ https://www.ncbi.nlm.nih.gov/pubmed/33409011 http://dx.doi.org/10.7759/cureus.11763 |
work_keys_str_mv | AT shimakawaurara acaseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection AT shigeharakeiichi acaseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection AT kawabeyasuhiro acaseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection AT ouchikazutaka acaseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection AT morijun acaseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection AT shimakawaurara caseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection AT shigeharakeiichi caseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection AT kawabeyasuhiro caseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection AT ouchikazutaka caseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection AT morijun caseofsaltwasting21hydroxylasedeficiencywithresistancetoaldosteroneduetourinarytractinfection |